International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia-A Critical Appraisal.

Autor: Albisetti M; University Children's Hospital, Zurich, Switzerland., Ardila J; Clínica Imbanaco Quirón Salud Hemophilia Center, IPS Especializada Coagulopathies Program, Universidad del Valle School of Public Health, Cali, Colombia., Astermark J; Department of Translational Medicine, Lund University, Lund, Sweden.; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Malmö, Sweden., Blatny J; Department of Paediatric Haematology and Biochemistry, University Hospital Brno and Masaryk University, Brno, Czech Republic and Hospital Bory, Bratislava, Slovakia., Carcao M; Division of Haematology/Oncology, Department of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Chowdary P; Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free London NHS Foundation Trust, London, UK., Connell NT; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Crato M; European Haemopilia Consortium, Brussels, Belgium., Dargaud Y; French Reference Center for Hemophilia, Clinical Haemostasis Unit, Louis Pradel Hospital, Hospices Civils de Lyon, Lyon, France.; Universite Claude Bernard Lyon 1 (UCLB), Lyon, France., d'Oiron R; Centre de Référence de l'Hémophilie et des Maladies Hémorragiques Rares, Hôpital Bicêtre APHP, and HITh, UMR_S1176, INSERM, Université Paris-Saclay, Le Kremlin-Bicêtre, Paris, France., Dunn AL; Nationwide Children's Hospital Division of Hematology, Oncology and Bone Marrow Transplant, Columbus, Ohio, USA., Escobar MA; University of Texas Health Science Center at Houston, Houston, Texas, USA., Ettingshausen CE; HZRM-Haemophilie Zentrum Rhein-Main, Frankfurt, Germany., Fischer K; Center for Benign Haematology, Thrombosis and Haemostasis Van Creveldkliniek, University Medical Center Utrecht, Utrecht, The Netherlands., Gouider E; Service d'hématologie biologique Hemophilia Center Aziza Othmana, University Tunis El Manar, Tunis, Tunisia., Harroche A; Service d'Hématologie Clinique Centre de Traitement de l'Hémophilie, Hôpital Necker Enfants Malades, AP-HP, Paris, France., Hermans C; Division of Adult Haematology, Cliniques Universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium., Jimenez-Yuste V; Hematology Department, Hospital Universitario La Paz-IdiPaz, Autonoma University, Madrid, Spain., Kaczmarek R; Indiana University School of Medicine, Indianapolis, Indiana, USA., Kenet G; The Israeli National Hemophilia Center and Thrombosis Research Institute, Sheba Medical Center, Tel Hashomer & Tel Aviv University, Ramat Gan, Israel., Khoo L; Haematology Department, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Klamroth R; Department for Internal Medicine and Vascular Medicine, Haemophilia Treatment Center, Vivantes Hospital im Friedrichshain, Berlin, Germany., Langer F; Department of Hematology and Oncology, University Medical Center Eppendorf, Hamburg, Germany., Lillicrap D; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada., Mahlangu J; Department of Molecular Medicine and Haematology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand and National Health Laboratory Service, Johannesburg, Gauteng, South Africa., Male C; Department of Paediatrics, Medical University of Vienna, Vienna, Austria., Mancuso ME; Center for Thrombosis and Hemorrhagic Diseases, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Matsushita T; Department of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan., Meunier S; Hospices Civils de Lyon- French Reference Center for Hemophilia, Clinical Haemostasis Unit Lyon, Louis Pradel Hospital, Bron, France., Miesbach W; Medical Clinic 2, University Hospital Frankfurt, Frankfurt, Germany., Nolan B; Children's Health Ireland at Crumlin, Dublin, Ireland., Oldenburg J; Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Medical Faculty, University of Bonn, Bonn, Germany., O'Mahony B; Irish Haemophilia Society, Dublin, Ireland., Ozelo M; Department of Internal Medicine, School of Medical Sciences, Hemocentro UNICAMP, University of Campinas, Campinas, SP, Brazil., Pierce GF; World Federation of Hemophilia, Montreal, Quebec, Canada., Ramos G; Reference Laboratory in Haemostasis and Hematology, National University, Bogotà, Colombia., Recht M; Yale University, New Haven, Connecticut, USA.; National Bleeding Disorders Foundation, New York, New York, USA., Romero-Lux O; European Haemopilia Consortium, Brussels, Belgium., Rotellini D; National Bleeding Disorders Foundation, New York, New York, USA., Santoro RC; Centre for Hemorrhagic and Thrombotic Disorders, Azienda Ospedaliera-Universitaria Renato Dulbecco, Catanzaro, Italy., Singleton TC; OchsnerClinic Foundation, Pediatric Hematology and Bone Marrow Transplant, New Orleans, Louisiana, USA., Skinner MW; Institute for Policy Development Ltd, Washington, District of Columbia, USA.; McMaster University, Hamilton, Ontario, Canada., Srivastava A; Haematology Research Unit, St. Johns Research Institute and Department of Clinical Haematology, St. John's Medical College Hospital, Bengaluru, India., Susen S; Hemostasis and Transfusion Department, University of Lille, Lille University Hospital, Lille, France., Talks K; Newcastle Haemophilia Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK., Tran H; The Alfred Hospital, Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia., Valentino LA; Hemophilia and Thrombophilia Center, Rush University Medical Center, Chicago, Illinois, USA., Windyga J; Department of Haemostasis Disorders and Internal Medicine, Laboratory of Haemostasis and Metabolic Diseases, Institute of Haematology and Transfusion Medicine, Warsaw, Poland., Yang R; Thrombosis and Hemostasis Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.

Publikováno v: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2024 Dec 06. Date of Electronic Publication: 2024 Dec 06.

Administration of gene therapy for haemophilia - The hub and spoke model and its regional differences and challenges.

Autor: Miesbach W; Medical Clinic 2, Institute of Transfusion Medicine, University Hospital Frankfurt, Frankfurt, Germany., Boban A; Haemophilia Centre, Department of Haematology, University Hospital Centre Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia., Chowdary P; Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London, UK., Coppens M; Hemophilia Treatment Center, Department of Vascular Medicine, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands.; Pulmonary Hypertension & Thrombosis, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands., Crato M; European Haemopilia Consortium, Brussels, Belgium., Jimenez-Yuste V; Hematology Department, Hospital Universitario La Paz-IdiPaz, Autonoma University, Madrid, Spain., Klamroth R; Department for Internal Medicine and Vascular Medicine, Haemophilia Treatment Center, Vivantes Hospital im Friedrichshain, Berlin, Germany., Makris M; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Mulders G; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands., Peyvandi F; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy.; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.

Publikováno v: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2024 May; Vol. 30 (3), pp. 855-857. Date of Electronic Publication: 2024 Mar 18.

European principles of inhibitor management in patients with haemophilia: implications of new treatment options

Autor: Hermans, C., Giangrande, P. L. F., O'Mahony, B., de Kleijn, P., Bedford, M., Batorova, A., Blatný, J., Jansone, K., Astermark, J., Crato, M., D'Oiron, R., Dougall, A., Fijnvandraat, K., Grønhaug, S., Jiménez-Yuste, V., Jokić, M., Lobet, S., Nolan, B., Peyvandi, F., Ryan, A.

Publikováno v: Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-4 (2020)
Orphanet journal of rare diseases, Vol. 15, no. 1, p. 219 [1-4] (2020)
Orphanet Journal of Rare Diseases
Orphanet journal of rare diseases, 15(1):219. BioMed Central

In light of the rapidly changing landscape of haemophilia treatment, the authors of the position paper on the “European Principles of Inhibitor Management” published in 2018 (Table 1) [1] now provide an update on the major impact of novel therapi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a8ccdf1d4b97b80b85bfdd70a4a0190
http://link.springer.com/article/10.1186/s13023-020-01511-8

Haemophilia A: health and economic burden of a rare disease in Portugal.

Autor: Café A; Market Access & External Affairs, Roche Farmacêutica Química, Lda, Estrada Nacional 249 - 1, 2720-413, Amadora, Portugal. andreia.cafe@roche.com., Carvalho M; Centro de Referência de Coagulopatias Congénitas do Centro Hospitalar Universitário S. João, EPE, Porto, Portugal., Crato M; Associação Portuguesa de Hemofilia e de Outras Coagulopatias Congénitas, Lisbon, Portugal., Faria M; Health Economics, Eurotrials Scientific Consultants, now part of CTI Clinical Trial & Consulting Services, Lisbon, Portugal., Kjollerstrom P; Unidade de Hematologia Pediátrica, Hospital Dona Estefânia, Centro Hospitalar Lisboa Central, Lisbon, Portugal., Oliveira C; Centro de Coagulopatias Congénitas do Hospital de Santa Maria, Lisbon, Portugal., Pinto PR; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS / 3B's - PT GovernmentAssociateLaboratory, Braga / Guimarães, Portugal., Salvado R; Centro de Coagulopatias Congénitas do Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal., Dos Santos AA; Centro de Referência de Coagulopatias Congénitas do Centro Hospitalar Lisboa Central - Hospital São José, Lisbon, Portugal., Silva C; Health Economics, Eurotrials Scientific Consultants, now part of CTI Clinical Trial & Consulting Services, Lisbon, Portugal.; CISP - Centro de Investigação em Saúde Pública, ENSP - Universidade Nova de Lisboa, Lisbon, Portugal.

Publikováno v: Orphanet journal of rare diseases [Orphanet J Rare Dis] 2019 Sep 04; Vol. 14 (1), pp. 211. Date of Electronic Publication: 2019 Sep 04.

RECONSTRUCTION OF THE MULTIELEMENT APPARATUS OF THE CONODONT GLADIGONDOLELLA TETHYDIS (HUCKRIEDE) USING MULTIVARIATE STATISTICAL ANALYSIS; IMPLICATIONS FOR TAXONOMY, STRATIGRAPHY, AND EVOLUTION.

Autor: GOLDING, MARTYN L.¹ martyn.golding@nrcan-rncan.gc.ca, KILIÇ, ALI M.² alimurat@balikesir.edu.tr

Publikováno v: Rivista Italiana di Paleontologia e Stratigrafia. Mar2024, Vol. 130 Issue 1, p1-18. 18p.